New York, NY, Sept. 01, 2025 (GLOBE NEWSWIRE) -- For most people, birdwatching begins with a fleeting moment: a small…
Singapore, Sept. 01, 2025 (GLOBE NEWSWIRE) -- Minus-AI: The Coolest AI Video Ad Agent https://youtu.be/HDyhkczn21k Minus-AI, a Singapore-based AI-native startup, has…
ZUG, Switzerland, Sept. 01, 2025 (GLOBE NEWSWIRE) -- Phase 2 ACUITY trial results for Privosegtor (OCS-05) in acute optic neuritis…
This press release is not intended for UK and US media. HERNEXEOS® (zongertinib tablets) has been approved based on an objective…
New York, Aug. 31, 2025 (GLOBE NEWSWIRE) -- August 31, 2025 | New York CrazyBulk proudly announces the release of…
New York City, NY, Aug. 31, 2025 (GLOBE NEWSWIRE) -- FY Energy, a global platform known for delivering encrypted, renewable-powered…
New York City, NY, Aug. 31, 2025 (GLOBE NEWSWIRE) -- As the crypto industry experiences a new wave of mainstream…
New York City, NY, Aug. 31, 2025 (GLOBE NEWSWIRE) -- As a historic shift in blockchain capital unfolds, FY Energy,…
-- Data Further Advance Understanding of VASCEPA®/VAZKEPA® Potential Mechanisms of Action -- August 31, 2025 08:30 ET | Source: Amarin…
Compared with tirzepatide, Wegovy® (semaglutide 2.4 mg) showed a significant 57% greater reduction in the risk of heart attack, stroke…